{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:08:55Z","timestamp":1755907735686,"version":"3.44.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SESHAD23B0","SHENOY23QI0"],"award-info":[{"award-number":["SESHAD23B0","SHENOY23QI0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clp.2025.06.004","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:08:30Z","timestamp":1752624510000},"page":"477-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cystic Fibrosis Newborn Screening"],"prefix":"10.1016","volume":"52","author":[{"given":"Ambika","family":"Shenoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Haskett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement L.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.clp.2025.06.004_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2025.06.004_bib2","unstructured":"Cystic fibrosis foundation patient registry 2024. Annual data report. Bethesda, Maryland. 2023."},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1542\/peds.46.3.335","article-title":"Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period","volume":"46","author":"Shwachman","year":"1970","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2025.06.004_bib4","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jpeds.2016.09.065","article-title":"Diagnosis of cystic fibrosis in screened populations","volume":"181S","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"issue":"RR-13","key":"10.1016\/j.clp.2025.06.004_bib5","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"8114","key":"10.1016\/j.clp.2025.06.004_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(79)90825-0","article-title":"Dried-blood spot screening for cystic fibrosis in the newborn","volume":"1","author":"Crossley","year":"1979","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.72.5.741","article-title":"Neonatal screening for cystic fibrosis: position paper","volume":"72","author":"Ad HOC Committee Task Force on Neonatal Screening CFF","year":"1983","journal-title":"Pediatrics"},{"issue":"14","key":"10.1016\/j.clp.2025.06.004_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM199710023371403","article-title":"Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin cystic fibrosis neonatal screening study group","volume":"337","author":"Farrell","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.107.1.1","article-title":"Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin cystic fibrosis neonatal screening study group","volume":"107","author":"Farrell","year":"2001","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib10","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1542\/peds.2006-1993","article-title":"Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic fibrosis foundation workshop report","volume":"119","author":"Comeau","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.85.6.1001","article-title":"Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels","volume":"85","author":"Rock","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2025.06.004_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpeds.2016.03.046","article-title":"Improving the sensitivity and positive predictive value in a cystic fibrosis newborn screening program using a repeat immunoreactive trypsinogen and genetic analysis","volume":"175","author":"Sontag","year":"2016","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1542\/peds.23.3.545","article-title":"A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis","volume":"23","author":"Gibson","year":"1959","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpeds.2007.03.002","article-title":"Diagnostic sweat testing: the cystic fibrosis foundation guidelines","volume":"151","author":"LeGrys","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2025.06.004_bib15","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ppul.26279","article-title":"Variation in cystic fibrosis newborn screening algorithms in the United States","volume":"58","author":"Rehani","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib17","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1542\/peds.2008-1681","article-title":"Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen","volume":"123","author":"Kloosterboer","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns11020024","article-title":"Cystic fibrosis newborn screening: a systematic review-driven consensus guideline of the cystic fibrosis foundation","volume":"11","author":"McGarry","year":"2024","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ppul.26209","article-title":"Detection of disease-causing CFTR variants in state newborn screening programs","volume":"58","author":"McGarry","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ppul.26253","article-title":"Refinement of newborn screening for cystic fibrosis with next generation sequencing","volume":"58","author":"Rock","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.clp.2025.06.004_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/ijns7040073","article-title":"Validation of a custom next-generation sequencing assay for cystic fibrosis newborn screening","volume":"7","author":"Sicko","year":"2021","journal-title":"Int J Neonatal Screen"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1542\/peds.2015-0811","article-title":"Newborn screening for cystic fibrosis in California","volume":"136","author":"Kharrazi","year":"2015","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.clp.2025.06.004_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ppul.23222","article-title":"Utility of a very high IRT\/No mutation referral category in cystic fibrosis newborn screening","volume":"50","author":"Kay","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jpeds.2006.07.026","article-title":"Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening","volume":"149","author":"Sontag","year":"2006","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib25","first-page":"113","article-title":"Cystic fibrosis: diagnostic considerations","volume":"150","author":"Rosenstein","year":"1982","journal-title":"Johns Hopkins Med J"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamapediatrics.2017.0206","article-title":"Effects of diagnosis by newborn screening for cystic fibrosis on weight and length in the first year of life","volume":"171","author":"Leung","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"10","key":"10.1016\/j.clp.2025.06.004_bib27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamapediatrics.2022.2674","article-title":"Real-world associations of US cystic fibrosis newborn screening programs with nutritional and pulmonary outcomes","volume":"176","author":"Rosenfeld","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"3 Suppl","key":"10.1016\/j.clp.2025.06.004_bib28","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jpeds.2005.08.003","article-title":"Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening","volume":"147","author":"Koscik","year":"2005","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1067\/mpd.2003.152","article-title":"Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis","volume":"142","author":"Konstan","year":"2003","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1542\/peds.2007-3089","article-title":"Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis","volume":"123","author":"Lai","year":"2009","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jpeds.2015.07.044","article-title":"Early life growth trajectories in cystic fibrosis are associated with pulmonary function at age 6 years","volume":"167","author":"Sanders","year":"2015","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ppul.10336","article-title":"Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis","volume":"36","author":"Farrell","year":"2003","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.clp.2025.06.004_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.2009","article-title":"Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition","volume":"32","author":"Kosorok","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"3 Suppl","key":"10.1016\/j.clp.2025.06.004_bib35","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jpeds.2005.08.013","article-title":"The influence of newborn screening for cystic fibrosis on pulmonary outcomes in New South Wales","volume":"147","author":"McKay","year":"2005","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib36","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thoraxjnl-2018-211706","article-title":"Impact of cystic fibrosis on birthweight: a population based study of children in Denmark and Wales","volume":"74","author":"Schluter","year":"2019","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.clp.2025.06.004_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thoraxjnl-2012-201747","article-title":"Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening","volume":"67","author":"Hoo","year":"2012","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.clp.2025.06.004_bib38","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/ppul.25538","article-title":"Hyperinflation is associated with increased respiratory rate and is a more sensitive measure of cystic fibrosis lung disease during infancy compared to forced expiratory measures","volume":"56","author":"Muston","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib39","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2009.05.005","article-title":"Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening","volume":"155","author":"Stick","year":"2009","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1164\/rccm.201507-1409OC","article-title":"Lung clearance index and structural lung disease on computed tomography in early cystic fibrosis","volume":"193","author":"Ramsey","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.clp.2025.06.004_bib41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1164\/rccm.201910-1943SO","article-title":"Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications","volume":"201","author":"Mall","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"10212","key":"10.1016\/j.clp.2025.06.004_bib42","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.clp.2025.06.004_bib43","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"author":"Foundation","key":"10.1016\/j.clp.2025.06.004_bib44"},{"issue":"6 Suppl","key":"10.1016\/j.clp.2025.06.004_bib45","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic fibrosis foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib46","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcf.2022.12.002","article-title":"High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results","volume":"22","author":"Ginsburg","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"3 Suppl","key":"10.1016\/j.clp.2025.06.004_bib48","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jpeds.2005.08.017","article-title":"Diagnostic dilemmas resulting from the immunoreactive trypsinogen\/DNA cystic fibrosis newborn screening algorithm","volume":"147","author":"Parad","year":"2005","journal-title":"J Pediatr"},{"issue":"11","key":"10.1016\/j.clp.2025.06.004_bib49","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ppul.21475","article-title":"Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome","volume":"46","author":"Ren","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2009.123422","article-title":"Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis","volume":"65","author":"Sermet-Gaudelus","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.clp.2025.06.004_bib51","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jpeds.2016.09.066","article-title":"Cystic Fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive, inconclusive diagnosis","volume":"181S","author":"Ren","year":"2017","journal-title":"J Pediatr"},{"issue":"Supplement 2","key":"10.1016\/j.clp.2025.06.004_bib52","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-Related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib53","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ppul.26950","article-title":"Clinical outcomes at 9-10 years of age in children born with cystic fibrosis transmembrane conductance regulator related metabolic syndrome","volume":"59","author":"Carroll","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib54","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051740","article-title":"Outcomes of cystic fibrosis screening-positive infants with inconclusive diagnosis at school age","volume":"148","author":"Gonska","year":"2021","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.clp.2025.06.004_bib55","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ppul.24634","article-title":"Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening","volume":"55","author":"Munck","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijns6010019","article-title":"Inconclusive diagnosis after newborn screening for cystic fibrosis","volume":"6","author":"Munck","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"10.1016\/j.clp.2025.06.004_bib57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2019.04.002","article-title":"Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): experience in tuscany, Italy","volume":"18","author":"Terlizzi","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib58","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib59","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064657","article-title":"Cystic fibrosis foundation evidence-based guideline for the management of CRMS\/CFSPID","volume":"153","author":"Green","year":"2024","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijns9010010","article-title":"Immunoreactive trypsinogen in infants born to women with cystic fibrosis taking Elexacaftor-Tezacaftor-Ivacaftor","volume":"9","author":"Patel","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib62","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcf.2021.03.018","article-title":"Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy","volume":"20","author":"Fortner","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.clp.2025.06.004_bib63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000530261","article-title":"Prenatal cystic fibrosis transmembrane conductance regulator modulator therapy: a promising way to change the impact of cystic fibrosis","volume":"50","author":"Gomez-Montes","year":"2023","journal-title":"Fetal Diagn Ther"},{"issue":"4","key":"10.1016\/j.clp.2025.06.004_bib64","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcf.2022.04.005","article-title":"A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.clp.2025.06.004_bib65","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7326\/L23-0112","article-title":"Treatment of fetal cystic fibrosis with cystic fibrosis transmembrane conductance regulator modulation therapy","volume":"176","author":"Blumenfeld","year":"2023","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib66","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jcf.2024.11.011","article-title":"Outcomes of prenatal use of elexacaftor\/tezacaftor\/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis","volume":"24","author":"Metcalf","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.clp.2025.06.004_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231050","article-title":"Newborn screening timeliness quality improvement initiative: impact of national recommendations and data repository","volume":"15","author":"Sontag","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clp.2025.06.004_bib68","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1542\/peds.2006-1639","article-title":"Primary care physicians\u2019 attitudes regarding follow-up care for children with positive newborn screening results","volume":"118","author":"Kemper","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib69","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0904","article-title":"Ensuring the life-span benefits of newborn screening","volume":"144","author":"Kemper","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2025.06.004_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijns8030038","article-title":"Newborn screening for cystic fibrosis: a qualitative study of successes and challenges from universal screening in the United States","volume":"8","author":"Sontag","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"6","key":"10.1016\/j.clp.2025.06.004_bib71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.46747\/cfp.6706439","article-title":"Primary care providers\u2019 role in newborn screening result notification for cystic fibrosis","volume":"67","author":"Hayeems","year":"2021","journal-title":"Can Fam Physician"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.1950060111","article-title":"Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test","volume":"6","author":"Rock","year":"1989","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ppul.20235","article-title":"Sweat-testing in preterm and full-term infants less than 6 weeks of age","volume":"40","author":"Eng","year":"2005","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib74","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13023-021-01965-4","article-title":"Health disparities among adults cared for at an urban cystic fibrosis program","volume":"16","author":"DiMango","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.clp.2025.06.004_bib75","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/ppul.23884","article-title":"Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: a longitudinal analysis","volume":"52","author":"McGarry","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.clp.2025.06.004_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcf.2022.07.010","article-title":"Disparities in first evaluation of infants with cystic fibrosis since implementation of newborn screening","volume":"22","author":"McColley","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.clp.2025.06.004_bib77","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/ppul.25658","article-title":"Outcomes of infants born during the first 9 years of CF newborn screening in the United States: a retrospective cystic fibrosis foundation patient registry cohort study","volume":"56","author":"Martiniano","year":"2021","journal-title":"Pediatr Pulmonol"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T20:27:48Z","timestamp":1755894468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510825000363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0095510825000363"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2025.06.004","relation":{},"ISSN":["0095-5108"],"issn-type":[{"type":"print","value":"0095-5108"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis Newborn Screening","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2025.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}